デジタルPCR (dPCR) 市場の予測：種類別、製品・サービス別、用途別、エンドユーザー別、地域別
Digital PCR (dPCR) Market - Forecast (2020 - 2025)
|デジタルPCR (dPCR) 市場の予測：種類別、製品・サービス別、用途別、エンドユーザー別、地域別|
ページ情報: 英文 108 Pages
当レポートでは、世界のデジタルPCR (dPCR) 市場について調査分析し、市場情勢、市場力学、戦略的分析、市場分析 (セグメント別) のほか、主要企業などについて、体系的な情報を提供しています。
Digital PCR Market Overview
Digital polymerase chain reaction (dPCR) is used to divide a sample of DNA or cDNA. Growing governmental initiatives in implementing better molecular diagnostic methods in diseases diagnosis is anticipated to foster the growth of the dPCR market. The digital polymerase chain reaction (dPCR) market was valued at $278.9m in 2017 and is estimated to reach $819.5m by 2023, growing at a CAGR of 19.89% during the forecast period 2018-2023. Europe holds the largest share in the market followed by Asia-Pacific owing to the rising geriatric population in these regions. Asia-Pacific is projected to witness the fastest growth during the forecast period owing to the rising R&D expenditure in the life sciences sector in various developing countries such as China and India.
Digital PCR Market Outlook
Digital polymerase chain reaction (dPCR), an advancement of traditional PCR, is used to detect and quantify DNA or a targeted part of DNA molecule. It distributes a sample of DNA or complementary DNA into many individual, parallel PCR reactions. It is used in various types of applications such as DNA cloning, diagnosis of hereditary diseases, functional analysis of genes, paternity testing, detection of infectious diseases, and forensic sciences. Its high precision, high tolerance to inhibitors, and high capacity to analyze complex combinations of DNA are some of the factors driving the dPCR market. The dPCR market is expected to grow globally due to the increase in number of infectious diseases and genetic disorders.
Digital PCR Market Growth Drivers
The growing demand for Digital PCR (dPCR) is due to the rapid technological advancements, increasing awareness about the benefits of early diagnosis of hereditary and infectious diseases, and growing demand for parental testing and gene study. The growing awareness among people regarding infectious diseases is significantly contributing to the growth of the digital PCR market. Technological improvements in medical applications is estimated to drive the dPCR market during the forecast period.
Digital PCR Market Challenges
Manufacturers need high initial costs in order to manufacture digital PCR system. In addition to this, high final device costs and technical limitations in digital PCR system, such as limited range of detection, are restraining the Digital PCR Market growth. Insufficient number of researchers and skilled laborers, and lack of proficient data analysis tools are hindering the market growth. Growing implementation of minimum information for publication of Quantitative Digital PCR Experiments for the independent evaluation of experimental data and comprehensive disclosure of all relevant details is challenging the market growth. Also high installation costs associated with dPCR is expected to restrain the growth of the dPCR market during the forecast period.
Digital PCR Market Research Scope
The base year of the study is 2017, with forecast done up to 2023. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the digital pcr in healthcare market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types and end users of Digital PCR, and their specific applications in the healthcare industry.
Digital PCR Market Report: Industry Coverage
Types of Digital PCR: Droplet dPCR, BEAMing dPCR
Product and Service type of Digital PCR: Instruments, Reagents and Consumables, Software and Services
Application of Digital PCR: Clinical, Research, Forensic
End Users of Digital PCR: Hospital, Diagnostic Center, Academia, Pharma-Biotech Co.
North America: The U.S., Canada, Mexico
South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica
Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark
APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong
The Middle East and Africa: Israel, South Africa, Saudi Arabia
Digital PCR Market Key Players Perspective
Some of the key players mentioned in this market research report include Thermo Fisher Scientific Inc. (the U.S.), Bio-Rad Laboratories, Inc. (the U.S.), RainDance Technologies, Inc. (the U.S.), Fluidigm Corporation (the U.S.), JN Medsys (Singapore), and Formulatrix Inc. (the U.S.).
Digital PCR Market Trends
Companies engaged in the Digital PCR market focused on product launches and acquisitions, which together accounted for 71.4% of the total development in 2017. Qiagen, Thermo Fisher Scientific, and Formulatrix are a few companies that employed acquisition strategies in the recent years.
Companies are also entering into new partnership agreements to open up new avenues in product development and achieve greater market exposure.
The clinical application segment of the digital PCR (DPCR) market accounted for $151.7m of the market share in 2017 and is projected to reach $471.2m by 2023, exhibiting a healthy CAGR of 21.01% during the forecast period.
Hospitals are the major end-users of digital PCR (dPCR), accounting for 50% share of the end user segment of dCPR market in 2017 owing to the increasing diagnosis of several diseases at early stages with increasing recovery rate.
As per IndustryARC analysis, the Americas region was the largest market for digital PCR (DPCR) with a share of 46% of the market in 2017, and the value is estimated to reach $360.6m by 2023 owing to the rising cancer cases.
"*Financials would be provided on a best efforts basis for private companies"